HEPATIC TUMORS

Clinical trials for HEPATIC TUMORS explained in plain language.

Never miss a new study

Get alerted when new HEPATIC TUMORS trials appear

Sign up with your email to follow new studies for HEPATIC TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New immunotherapy combo shows promise for young cancer patients

Disease control Ongoing

This study tests two immunotherapy drugs, cobolimab and dostarlimab, together in children and young adults (up to age 21) with advanced solid tumors that have not responded to other treatments. The goal is to find the safest dose and see if the combination can shrink tumors. The …

Matched conditions: HEPATIC TUMORS

Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control

Last updated May 22, 2026 13:50 UTC

HEPATIC TUMORS

Get alerted when new HEPATIC TUMORS trials appear

New immunotherapy combo shows promise for young cancer patients